
zzso Medical and zzso are developing zzso an zzso zzso zzso magnetic resonance imaging contrast agent, for the potential imaging of blood vessels and blood flow, particularly in patients with peripheral vascular disease zzso By February 2004, US approval of the agent was anticipated in October 2004, and in June 2004, zzso filed an zzso in the zzso for zzso 

